About Ochsner Hematology Oncology North Shore - Slidell (East Region)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Ochsner Hematology Oncology North Shore - Slidell (East Region)
During the past decade, Ochsner Hematology Oncology North Shore - Slidell (East Region) conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ochsner Hematology Oncology North Shore - Slidell (East Region)" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "ECOG-ACRIN Cancer Research Group" with 2 trials
sponsored, "ElectroCore INC" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "SWOG Cancer Research Network"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ochsner Hematology Oncology North Shore - Slidell (East Region)"
#1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Ochsner Hematology Oncology North Shore - Slidell (East Region)
According to Clinical.Site data, the most researched conditions in "Ochsner Hematology Oncology North Shore - Slidell (East Region)" are
"Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials) and "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (2 trials). Many other conditions were trialed in "Ochsner Hematology Oncology North Shore - Slidell (East Region)" in a lesser frequency.
Clinical Trials Intervention Types at Ochsner Hematology Oncology North Shore - Slidell (East Region)
Most popular intervention types in "Ochsner Hematology Oncology North Shore - Slidell (East Region)" are "Drug" (6 trials), "Other" (6 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Cisplatin" (3 trials), "Clinical Observation" (3 trials), "Paclitaxel" (3 trials) and "Biospecimen Collection" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Ochsner Hematology Oncology North Shore - Slidell (East Region)
The vast majority of trials in "Ochsner Hematology Oncology North Shore - Slidell (East Region)" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Ochsner Hematology Oncology North Shore - Slidell (East Region)
Currently, there are NaN active trials in "Ochsner Hematology Oncology North Shore - Slidell (East Region)".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ochsner Hematology Oncology North Shore - Slidell (East Region),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ochsner Hematology Oncology North Shore - Slidell (East Region), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".